MXCT

MKT CAP:$126M

MaxCyte Inc

Market Cap

$126M

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$1.14-$0.41 (-26.45%)

Jun 5, 2026

52W High $2.3352W Low $0.68

Company Details

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medi...

CEO

—

IPO Date

Jul 30, 2021

Website

www.maxcyte.com

Key Metrics TTM

Revenue

$32M

-14.3% YoY

Net Income

-$39M

EPS (Diluted)

Free Cash Flow

-$30M

Revenue / Share

$0.30

Gross Margin

80.7%

Operating Margin

-119.7%

Net Margin

-121.2%

FCF Margin

-91.4%

P/S

3.9x

P/E

Earnings Reports

Q1 2026

May 13, 2026

$10M-7.1%

FY 2025

Mar 25, 2026

$33M-14.5%

Q4 2025

Mar 25, 2026

$7M-16.0%

Q3 2025

Nov 13, 2025

$7M-16.4%

Q2 2025

Aug 6, 2025

$9M-18.4%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee